Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_assertion type Assertion NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_head.
- NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_assertion wasGeneratedBy ECO_0000203 NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_provenance.
- NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_assertion wasDerivedFrom befree-20150227 NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_provenance.
- NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_assertion SIO_000772 12118245 NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_provenance.
- NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_assertion evidence source_evidence_literature NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_provenance.
- NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_assertion description "[Most importantly, Smac peptides strongly enhanced the antitumor activity of Apo-2L/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in an intracranial malignant glioma xenograft model in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923505.RALCUB-igRKrI2lDBecAqaz5mta2uJiyS7xEl--ksE4nE130_provenance.